{"hands_on_practices": [{"introduction": "The final step in a colorimetric ELISA is the spectrophotometric measurement of absorbance, which reflects the amount of colored product generated by the enzyme. To make this measurement quantitatively useful, it must be converted into the concentration of the product. This fundamental exercise applies the Beer-Lambert law, $A = \\epsilon c l$, to bridge the gap between the raw optical signal from the instrument and a meaningful chemical quantity, forming the basis of all subsequent quantitative analysis. [@problem_id:5107676]", "problem": "In a direct Enzyme-Linked Immunosorbent Assay (ELISA) for antigen detection, the antigen is immobilized on a polystyrene microplate well and probed with an enzyme-labeled primary antibody, where the enzyme is horseradish peroxidase (HRP). Upon addition of the chromogenic substrate tetramethylbenzidine (TMB), the reaction is acid-stopped to yield the yellow product that is read at $450\\ \\mathrm{nm}$. A single well gives a blank-corrected absorbance of $A_{450} = 0.800$. The microplate’s effective optical pathlength for the well volume used is $l_{\\mathrm{eff}} = 0.50\\ \\mathrm{cm}$. The decadic molar extinction coefficient of the acid-stopped TMB product at $450\\ \\mathrm{nm}$ in the assay buffer is $\\epsilon_{450} = 5.9 \\times 10^{4}\\ \\mathrm{M}^{-1}\\ \\mathrm{cm}^{-1}$. Assuming a linear, non-scattering regime and that the absorbance arises solely from the product in the well, determine the molar concentration $c_{\\mathrm{prod}}$ of the product in the well. Express your final answer in micromolar ($\\mu\\mathrm{M}$) and round to four significant figures.", "solution": "The problem statement is first subjected to a validation process to ensure its scientific and logical integrity.\n\n### Step 1: Extract Givens\n- **Assay Type**: Direct Enzyme-Linked Immunosorbent Assay (ELISA) for antigen detection.\n- **Enzyme-Substrate System**: Horseradish peroxidase (HRP) enzyme with tetramethylbenzidine (TMB) as the chromogenic substrate, followed by an acid-stop step.\n- **Measurement Wavelength**: $\\lambda = 450\\ \\mathrm{nm}$.\n- **Blank-Corrected Absorbance**: $A_{450} = 0.800$.\n- **Effective Optical Pathlength**: $l_{\\mathrm{eff}} = 0.50\\ \\mathrm{cm}$.\n- **Decadic Molar Extinction Coefficient**: $\\epsilon_{450} = 5.9 \\times 10^{4}\\ \\mathrm{M}^{-1}\\ \\mathrm{cm}^{-1}$.\n- **Assumptions**: The system is in a linear, non-scattering regime, and the measured absorbance is solely due to the TMB product.\n- **Objective**: Determine the molar concentration of the product, $c_{\\mathrm{prod}}$, in the well.\n- **Output Requirements**: The final answer must be in units of micromolar ($\\mu\\mathrm{M}$) and rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientific Grounding**: The problem describes a standard biochemical assay (ELISA) and relies on the Beer-Lambert Law, a fundamental principle of spectrophotometry. The provided values for absorbance ($A_{450} = 0.800$), optical pathlength ($l_{\\mathrm{eff}} = 0.50\\ \\mathrm{cm}$), and molar extinction coefficient ($\\epsilon_{450} = 5.9 \\times 10^{4}\\ \\mathrm{M}^{-1}\\ \\mathrm{cm}^{-1}$) are physically realistic and consistent with values reported in immunodiagnostics literature for this type of assay. The procedure described (HRP/TMB, acid stop, read at $450\\ \\mathrm{nm}$) is standard practice.\n- **Well-Posedness**: The problem is well-posed. It provides all necessary parameters ($A$, $\\epsilon$, $l$) to uniquely determine the unknown concentration ($c$) using the Beer-Lambert Law.\n- **Objectivity**: The problem is stated using clear, objective, and quantitative language.\n\n### Step 3: Verdict and Action\nThe problem is scientifically grounded, well-posed, and objective. It contains no inconsistencies, ambiguities, or factual errors. Therefore, the problem is deemed **valid**. A solution will be derived.\n\nThe relationship between absorbance, concentration, and pathlength for a non-scattering medium is described by the Beer-Lambert Law. The law is expressed as:\n$$A = \\epsilon c l$$\nwhere $A$ is the dimensionless absorbance, $\\epsilon$ is the molar extinction coefficient (in units of $\\mathrm{M}^{-1}\\ \\mathrm{cm}^{-1}$), $c$ is the molar concentration (in units of $\\mathrm{M}$), and $l$ is the optical pathlength (in units of $\\mathrm{cm}$).\n\nThe problem provides the following values:\n- Blank-corrected absorbance at $450\\ \\mathrm{nm}$: $A_{450} = 0.800$\n- Molar extinction coefficient of the product at $450\\ \\mathrm{nm}$: $\\epsilon_{450} = 5.9 \\times 10^{4}\\ \\mathrm{M}^{-1}\\ \\mathrm{cm}^{-1}$\n- Effective optical pathlength: $l_{\\mathrm{eff}} = 0.50\\ \\mathrm{cm}$\n\nWe are tasked with finding the molar concentration of the product, denoted as $c_{\\mathrm{prod}}$. We can rearrange the Beer-Lambert Law to solve for $c_{\\mathrm{prod}}$:\n$$c_{\\mathrm{prod}} = \\frac{A_{450}}{\\epsilon_{450} \\cdot l_{\\mathrm{eff}}}$$\nSubstituting the given values into this equation:\n$$c_{\\mathrm{prod}} = \\frac{0.800}{(5.9 \\times 10^{4}\\ \\mathrm{M}^{-1}\\ \\mathrm{cm}^{-1}) \\cdot (0.50\\ \\mathrm{cm})}$$\nFirst, we calculate the product in the denominator:\n$$\\epsilon_{450} \\cdot l_{\\mathrm{eff}} = (5.9 \\times 10^{4}\\ \\mathrm{M}^{-1}\\ \\mathrm{cm}^{-1}) \\cdot (0.50\\ \\mathrm{cm}) = 2.95 \\times 10^{4}\\ \\mathrm{M}^{-1}\\ \\mathrm{cm}$$\nNow, we can calculate the concentration $c_{\\mathrm{prod}}$ in units of moles per liter ($\\mathrm{M}$):\n$$c_{\\mathrm{prod}} = \\frac{0.800}{2.95 \\times 10^{4}}\\ \\mathrm{M} \\approx 2.7118644 \\times 10^{-5}\\ \\mathrm{M}$$\nThe problem requires the answer to be expressed in micromolar ($\\mu\\mathrm{M}$). We use the conversion factor $1\\ \\mathrm{M} = 10^{6}\\ \\mu\\mathrm{M}$:\n$$c_{\\mathrm{prod}} (\\mu\\mathrm{M}) = c_{\\mathrm{prod}} (\\mathrm{M}) \\times 10^{6}\\ \\frac{\\mu\\mathrm{M}}{\\mathrm{M}}$$\n$$c_{\\mathrm{prod}} (\\mu\\mathrm{M}) = (2.7118644 \\times 10^{-5}) \\times 10^{6}\\ \\mu\\mathrm{M} = 27.118644\\ \\mu\\mathrm{M}$$\nFinally, we must round the result to four significant figures. The first four significant figures are $2$, $7$, $1$, and $1$. The fifth significant figure is $8$, which is greater than or equal to $5$, so we round up the fourth significant figure.\n$$c_{\\mathrm{prod}} \\approx 27.12\\ \\mu\\mathrm{M}$$", "answer": "$$\\boxed{27.12}$$", "id": "5107676"}, {"introduction": "Moving from idealized buffers to real-world diagnostics requires confronting the complexity of biological samples. These samples contain a myriad of \"matrix\" proteins and other molecules that can cause nonspecific signal and interfere with the assay. This practice addresses a core challenge in assay development: optimizing sample dilution to minimize these matrix effects without diluting the target antigen below the assay's limit of detection. [@problem_id:5107684] This exercise will hone your ability to navigate the critical trade-offs inherent in designing a robust immunoassay.", "problem": "A laboratory is optimizing a Direct Enzyme-Linked Immunosorbent Assay (ELISA) for antigen detection in a complex biological matrix. The specimen contains a high concentration of non-target matrix proteins that must be diluted to mitigate non-specific interactions and reduce background. The foundational premises are: conservation of mass under dilution, the definition of dilution factor as a volume ratio, and the concept that the Limit of Detection (LOD) in immunoassays corresponds to the minimum analyte concentration that yields a signal distinguishable from noise under specified conditions.\n\nYou are given the following scientifically consistent parameters for a single-sample dilution prior to plate loading:\n- Initial matrix protein concentration $C_{m,0} = 60$ mg/mL. The acceptable matrix protein concentration threshold to achieve low background is $C_{m,\\mathrm{thr}} = 1$ mg/mL.\n- Initial antigen concentration $C_{a,0} = 2$ $\\mu$g/mL.\n- The assay’s current Limit of Detection $C_{\\mathrm{LOD}} = 50$ ng/mL for the antigen under the chosen detection chemistry and reading conditions.\n\nAssume that dilution by a dimensionless fold factor $D$ leaves the molecular identity of the antigen intact and scales all solute concentrations by $1/D$, and that the ELISA response is linear with concentration within the working range near the LOD. The objectives are:\n1. Reduce the matrix protein concentration to at or below $C_{m,\\mathrm{thr}}$ via dilution.\n2. Keep the antigen concentration in the diluted sample at or above $C_{\\mathrm{LOD}}$.\n\nIf a single dilution factor $D$ that satisfies both objectives does not exist, determine the minimum multiplicative improvement factor $F$ by which the LOD must be reduced (that is, the new LOD becomes $C_{\\mathrm{LOD}}/F$) so that a single dilution factor can simultaneously satisfy both constraints.\n\nExpress the final answer as the dimensionless fold-improvement $F$. Round your answer to three significant figures.", "solution": "The user-provided problem has been rigorously validated. All givens were extracted verbatim, and the problem was assessed against the specified criteria.\n\n**Givens:**\n- Initial matrix protein concentration: $C_{m,0} = 60$ mg/mL.\n- Acceptable matrix protein concentration threshold: $C_{m,\\mathrm{thr}} = 1$ mg/mL.\n- Initial antigen concentration: $C_{a,0} = 2$ $\\mu$g/mL.\n- Assay's Limit of Detection for antigen: $C_{\\mathrm{LOD}} = 50$ ng/mL.\n- Objective 1: Reduce matrix protein concentration such that its final concentration is $\\le C_{m,\\mathrm{thr}}$.\n- Objective 2: Keep antigen concentration such that its final concentration is $\\ge C_{\\mathrm{LOD}}$.\n\n**Validation Verdict:**\nThe problem is **valid**. It is scientifically grounded in the principles of immunodiagnostics and analytical chemistry. It is well-posed, with all necessary parameters provided and a clear, objective goal. The premises are internally consistent and realistic. The problem requires a logical derivation based on competing constraints, which is a standard task in assay optimization.\n\n**Solution:**\nLet $D$ be the dimensionless dilution factor applied to the initial sample. The concentrations of the matrix proteins ($C_m$) and the antigen ($C_a$) in the diluted sample are given by:\n$$ C_m = \\frac{C_{m,0}}{D} $$\n$$ C_a = \\frac{C_{a,0}}{D} $$\n\nWe must satisfy two constraints simultaneously.\n\n**Constraint 1: Matrix Protein Concentration**\nThe concentration of matrix proteins in the diluted sample must be at or below the acceptable threshold, $C_{m,\\mathrm{thr}}$.\n$$ \\frac{C_{m,0}}{D} \\le C_{m,\\mathrm{thr}} $$\nSolving for $D$, we find a lower bound for the dilution factor:\n$$ D \\ge \\frac{C_{m,0}}{C_{m,\\mathrm{thr}}} $$\nLet us define this minimum required dilution as $D_{\\min}$.\n$$ D_{\\min} = \\frac{C_{m,0}}{C_{m,\\mathrm{thr}}} = \\frac{60 \\text{ mg/mL}}{1 \\text{ mg/mL}} = 60 $$\nThus, to mitigate matrix effects, the dilution factor must be at least $60$.\n\n**Constraint 2: Antigen Concentration**\nThe concentration of the antigen in the diluted sample must be at or above the limit of detection, $C_{\\mathrm{LOD}}$.\n$$ \\frac{C_{a,0}}{D} \\ge C_{\\mathrm{LOD}} $$\nSolving for $D$, we find an upper bound for the dilution factor:\n$$ D \\le \\frac{C_{a,0}}{C_{\\mathrm{LOD}}} $$\nLet us define this maximum allowable dilution as $D_{\\max}$. Before calculating its value, we must ensure the units are consistent. The initial antigen concentration is $C_{a,0} = 2$ $\\mu$g/mL, which is equivalent to $2 \\times 10^3$ ng/mL. The limit of detection is $C_{\\mathrm{LOD}} = 50$ ng/mL.\n$$ D_{\\max} = \\frac{2 \\times 10^3 \\text{ ng/mL}}{50 \\text{ ng/mL}} = \\frac{2000}{50} = 40 $$\nThus, to ensure the antigen is detectable, the dilution factor must be no more than $40$.\n\n**Analysis of Feasibility**\nFor a single dilution factor $D$ to satisfy both objectives, it must be true that $D_{\\min} \\le D \\le D_{\\max}$. Substituting our calculated values, we require a $D$ such that:\n$$ 60 \\le D \\le 40 $$\nThis inequality has no solution, as $60 > 40$. Therefore, no single dilution factor can simultaneously meet both the matrix reduction and antigen detection requirements with the current assay parameters.\n\n**Determining the Required LOD Improvement**\nThe problem asks for the minimum multiplicative improvement factor, $F$, by which the LOD must be reduced to make a solution possible. The new, improved limit of detection, $C'_{\\mathrm{LOD}}$, is given by:\n$$ C'_{\\mathrm{LOD}} = \\frac{C_{\\mathrm{LOD}}}{F} $$\nWith this new LOD, the second constraint becomes:\n$$ \\frac{C_{a,0}}{D} \\ge C'_{\\mathrm{LOD}} = \\frac{C_{\\mathrm{LOD}}}{F} $$\nThis yields a new maximum allowable dilution factor, $D'_{\\max}$:\n$$ D \\le \\frac{F \\cdot C_{a,0}}{C_{\\mathrm{LOD}}} = F \\cdot D_{\\max} $$\nSo, $D'_{\\max} = F \\cdot D_{\\max}$. The first constraint on the minimum dilution, $D \\ge D_{\\min}$, is unaffected.\n\nFor a valid dilution factor $D$ to exist, the condition $D_{\\min} \\le D \\le D'_{\\max}$ must be satisfiable. This is possible if and only if the lower bound is less than or equal to the upper bound:\n$$ D_{\\min} \\le D'_{\\max} $$\n$$ D_{\\min} \\le F \\cdot D_{\\max} $$\nWe are looking for the *minimum* factor $F$ that satisfies this. The minimum value of $F$ is that which makes the inequality an equality, representing the threshold at which a solution becomes possible (specifically, a single point solution where $D = D_{\\min} = D'_{\\max}$).\n$$ F_{\\min} = \\frac{D_{\\min}}{D_{\\max}} $$\nSubstituting the values we calculated:\n$$ F_{\\min} = \\frac{60}{40} = 1.5 $$\nThe problem requires the answer to be rounded to three significant figures. The exact value of $1.5$ is written as $1.50$ to convey this precision.\nTherefore, the limit of detection must be improved by a factor of at least $1.50$. This would reduce the LOD from $50$ ng/mL to $50/1.50 \\approx 33.3$ ng/mL, making a dilution of $D=60$ feasible.", "answer": "$$\\boxed{1.50}$$", "id": "5107684"}, {"introduction": "Once an assay protocol is established, its performance must be formally validated in the intended biological matrix. The spike-and-recovery experiment is a cornerstone of this validation process, designed to quantify the influence of the sample matrix on assay accuracy. By adding a known amount of antigen (a \"spike\") into a sample and measuring how much is detected (the \"recovery\"), we can calculate a recovery percentage that directly measures signal suppression or enhancement. [@problem_id:5107702] This practice provides hands-on experience in executing and interpreting one of the most important procedures for ensuring an immunoassay is reliable and fit-for-purpose.", "problem": "A laboratory is validating a direct Enzyme-Linked Immunosorbent Assay (ELISA) for antigen detection in a complex biological matrix using spike-and-recovery. In direct ELISA, antigen present in the sample adheres to the polystyrene surface, and an enzyme-labeled primary antibody binds directly to the immobilized antigen, generating an absorbance signal after substrate conversion. Under low occupancy conditions where surface binding sites are far from saturation, the measured absorbance is proportional to the mass of bound antigen, which is in turn proportional to the bulk antigen concentration in the coating solution. Assume the following fundamental base:\n\n- The absorbance $A$ is related to the bound antigen mass $m_{b}$ through $A = k\\,m_{b} + A_{0}$, where $k$ is an assay-dependent proportionality constant and $A_{0}$ is the baseline absorbance arising from non-specific signal and instrumental offset.\n- Under low occupancy, $m_{b} = \\eta\\,V\\,C$, where $\\eta$ is the effective capture efficiency onto the surface, $V$ is the coated volume per well, and $C$ is the antigen concentration in the coating solution. Thus, $A = s\\,C + A_{0}$ with $s = k\\,\\eta\\,V$.\n- A calibration prepared in an inert buffer (no matrix) defines the buffer slope $s_{\\mathrm{buf}}$ and baseline $A_{0}$, whereas the matrix may alter the effective capture efficiency relative to buffer.\n\nA two-point buffer calibration yields $A = A_{0}$ at $C = 0\\,\\mathrm{ng/mL}$, and a linear response at a known calibrator concentration. Specifically, a blank buffer well gives $A = 0.040$ at $C = 0\\,\\mathrm{ng/mL}$, and the $5\\,\\mathrm{ng/mL}$ buffer calibrator gives $A = 0.665$. A biological sample matrix is tested without spike and with a pre-coating spike of the antigen. The unspiked matrix yields $A_{\\mathrm{unsp}} = 0.280$, and the matrix spiked by $\\Delta C_{\\mathrm{true}} = 2.0\\,\\mathrm{ng/mL}$ (added to the matrix prior to coating) yields $A_{\\mathrm{sp}} = 0.500$. Assume identical coated volume $V$ and identical incubation, wash, and detection conditions across all wells, and that the assay is operating in the low-occupancy linear regime.\n\nUsing the buffer calibration to compute apparent concentrations from matrix signals, derive the spike recovery fraction $R$ defined as the ratio of the observed increase in apparent concentration to the known added concentration, that is $R = \\Delta C_{\\mathrm{app}}/\\Delta C_{\\mathrm{true}}$, and interpret $R$ with respect to matrix effects under the linear model. Express the final value of $R$ as a unitless decimal fraction and round your answer to four significant figures.", "solution": "The problem requires the calculation of a spike recovery fraction, $R$, for a direct ELISA, and an interpretation of this value. The analysis is predicated on a linear model relating absorbance ($A$) to antigen concentration ($C$): $A = sC + A_0$. The slope, $s$, represents the assay's sensitivity and can be different for the assay buffer ($s_{\\mathrm{buf}}$) and the biological matrix ($s_{\\mathrm{mat}}$). The intercept, $A_0$, is the baseline absorbance.\n\nFirst, we determine the parameters of the buffer calibration curve, which is used to calculate \"apparent concentrations\" ($C_{\\mathrm{app}}$). The governing equation for the buffer is $A = s_{\\mathrm{buf}}C_{\\mathrm{app}} + A_0$.\n\nThe problem provides two data points for the buffer calibration:\n1. Blank buffer: A concentration of $C = 0\\,\\mathrm{ng/mL}$ yields an absorbance of $A = 0.040$.\n2. Buffer calibrator: A concentration of $C = 5.0\\,\\mathrm{ng/mL}$ yields an absorbance of $A = 0.665$.\n\nFrom the blank buffer measurement, we directly identify the baseline absorbance, $A_0$:\n$$A_0 = 0.040$$\n\nUsing both calibration points, we can calculate the slope of the buffer calibration curve, $s_{\\mathrm{buf}}$:\n$$s_{\\mathrm{buf}} = \\frac{\\Delta A}{\\Delta C} = \\frac{0.665 - 0.040}{5.0\\,\\mathrm{ng/mL} - 0\\,\\mathrm{ng/mL}} = \\frac{0.625}{5.0\\,\\mathrm{ng/mL}} = 0.125\\,\\mathrm{mL/ng}$$\n\nThe complete buffer calibration equation is $A = (0.125) C_{\\mathrm{app}} + 0.040$. To determine the apparent concentration from any measured absorbance, we can rearrange this equation:\n$$C_{\\mathrm{app}} = \\frac{A - A_0}{s_{\\mathrm{buf}}} = \\frac{A - 0.040}{0.125}$$\n\nNext, we use this calibration relationship to find the apparent concentrations in the matrix samples.\nFor the unspiked matrix, the measured absorbance is $A_{\\mathrm{unsp}} = 0.280$. The corresponding apparent concentration of the endogenous antigen, $C_{\\mathrm{app,unsp}}$, is:\n$$C_{\\mathrm{app,unsp}} = \\frac{A_{\\mathrm{unsp}} - A_0}{s_{\\mathrm{buf}}} = \\frac{0.280 - 0.040}{0.125} = \\frac{0.240}{0.125} = 1.92\\,\\mathrm{ng/mL}$$\n\nFor the matrix spiked with a true concentration increase of $\\Delta C_{\\mathrm{true}} = 2.0\\,\\mathrm{ng/mL}$, the measured absorbance is $A_{\\mathrm{sp}} = 0.500$. The total apparent concentration in this spiked sample, $C_{\\mathrm{app,sp}}$, is:\n$$C_{\\mathrm{app,sp}} = \\frac{A_{\\mathrm{sp}} - A_0}{s_{\\mathrm{buf}}} = \\frac{0.500 - 0.040}{0.125} = \\frac{0.460}{0.125} = 3.68\\,\\mathrm{ng/mL}$$\n\nThe observed increase in apparent concentration, $\\Delta C_{\\mathrm{app}}$, is the difference between the apparent concentrations of the spiked and unspiked samples:\n$$\\Delta C_{\\mathrm{app}} = C_{\\mathrm{app,sp}} - C_{\\mathrm{app,unsp}} = 3.68\\,\\mathrm{ng/mL} - 1.92\\,\\mathrm{ng/mL} = 1.76\\,\\mathrm{ng/mL}$$\n\nThe spike recovery fraction, $R$, is defined as the ratio of the observed increase in apparent concentration to the true increase in concentration:\n$$R = \\frac{\\Delta C_{\\mathrm{app}}}{\\Delta C_{\\mathrm{true}}}$$\nSubstituting the calculated and given values:\n$$R = \\frac{1.76\\,\\mathrm{ng/mL}}{2.0\\,\\mathrm{ng/mL}} = 0.88$$\nAs per the instruction to round to four significant figures, the result is $0.8800$.\n\nThe physical interpretation of the recovery fraction $R$ provides insight into the matrix effect. The change in absorbance due to spiking is $\\Delta A = A_{\\mathrm{sp}} - A_{\\mathrm{unsp}}$. In the matrix, this change is related to the true spike concentration by the matrix sensitivity, $s_{\\mathrm{mat}}$: $\\Delta A = s_{\\mathrm{mat}} \\Delta C_{\\mathrm{true}}$. When analyzed using the buffer calibration, the same absorbance change corresponds to the apparent concentration change: $\\Delta A = s_{\\mathrm{buf}} \\Delta C_{\\mathrm{app}}$. By equating these two expressions for $\\Delta A$, we find $s_{\\mathrm{mat}} \\Delta C_{\\mathrm{true}} = s_{\\mathrm{buf}} \\Delta C_{\\mathrm{app}}$. Rearranging this gives the relationship:\n$$R = \\frac{\\Delta C_{\\mathrm{app}}}{\\Delta C_{\\mathrm{true}}} = \\frac{s_{\\mathrm{mat}}}{s_{\\mathrm{buf}}}$$\nThus, the spike recovery fraction $R$ is precisely the ratio of the assay's sensitivity in the matrix to its sensitivity in the buffer. A value of $R=1.0$ would indicate no matrix effect on the assay's sensitivity. In this problem, $R = 0.88$, which is less than $1$. This indicates a suppressive matrix effect, meaning the assay is less sensitive in the biological matrix than in the clean buffer. Specifically, the sensitivity in the matrix is only $88\\%$ of the sensitivity in the buffer. This suppression is likely caused by components in the matrix interfering with the antigen's ability to bind to the assay surface, thereby reducing the effective capture efficiency ($\\eta_{\\mathrm{mat}}  \\eta_{\\mathrm{buf}}$).", "answer": "$$\\boxed{0.8800}$$", "id": "5107702"}]}